|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke or,cardiov ascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 2 | Parenteral anticoagulants:Antithrombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence-based clinical practice guidelines显示文摘 | Garcia DA Baglin TP Weitz JI | 2012 | Chest2012，141，2： | 1 |
| 3 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 4 | New antithromboticdrugs:American College of Chest Physicians evidence-basedclinical practice guidelines(8th edition)显示文摘 | WEITZ JI HIRSH J SAMAMA MM | 2008 | Chest2008，133，6： | 1 |
| 5 | Low molecular weight heparins显示文摘 | Weitz JI | 1997 | N Engl J Med1997，337，： | 1 |
| 6 | New antithrombotic drugs : American College of Chest Physicians evidence-based clin- ical practice guidelines (8th edition) 显示文摘 | Weitz JI Hirsh J Samama MM | 2008 | Chest2008，133，6： | 1 |
| 7 | New antithrombitic drugs:Anti-thrombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence-based clinical practice guidelines显示文摘 | Weitz JI Eikelboom JW Samama MM | 2012 | Chest2012，141，2： | 1 |
| 8 | Clot-bound thrombin is protected from inhibition by heparin-antithrombin Ⅲ but is susceptible to inactivation by antithrombin Ⅲ-independent inhibitors显示文摘 | Weitz JI Hudoba M Massel D | 1990 | J Clin Invest1990，86，： | 1 |
| 9 | Hypercoagulable states显示文摘 | Anderson JA Weitz JI | 2010 | Clin Chest Med2010，31，4： | 1 |
| 10 | New antithrombotic drugs:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines显示文摘 | Weitz JI Eikelboom JW Samama MM | 2012 | Chest2012，141，21： | 1 |
| 11 | Diagnosis and treatment of chronic arterial insufficiency of the lower extremities:a critical review显示文摘 | Byrne J Clagett GP | 1996 | Circulation1996，94，： | 1 |
| 12 | Antithrombin- independent anticoagulation by hypersulfated low-molecu- lar-weight heparin显示文摘 | Fredenburgh JC Anderson JAM Weitz JI | 2012 | Trends Cardiovasc Med2012，12，7： | 1 |
| 13 | Diagnosis and treatment of chronic arterial insufficiency of the lower extremities,a critical review 显示文摘 | Weitz JI Byme J Clagett GP | 1996 | Circulation1996，94，11： | 1 |
| 14 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 15 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial, stroke, or cardiovascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 16 | New Anticoagulant Drugs显示文摘 | Weitz JI Hirsh J | 2001 | Chest2001，119，： | 1 |
| 17 | Selective factor Xa inhibition for thromboprophylaxis 显示文摘 | Eikelboom JW Weitz JI | 2008 | Lancet2008，372，9632： | 1 |
| 18 | New antithrombotic drugs: American College of Chest Physicians Evidence-based Clinical Practice Guidelines(8th edition)显示文摘 | Weitz JI Hirsh J Samama MM | 2008 | Chest2008，133，6： | 1 |
| 19 | Update on antithrombotic therapy:new anticoagulants显示文摘 | EIKELBOOM JW WEITZ JI | 2010 | Circulation2010，121，13： | 1 |
| 20 | Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation:results of a randomised trial显示文摘 | Flather MD Weitz JI Pogue J | 2000 | Eur Heart J2000，21，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员